Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aroplatin and gemcitabine in advanced pancreatic cancer
NCT00081549Phase 2Unknown
- Sponsor
- Aronex Pharmaceuticals, Inc.
- Modality
- Lipid-based Nanoparticles, Small Molecules
01
Overview
A Phase 2 trial of liposomal NDDP in pancreatic cancer (PC), sponsored by Aronex Pharmaceuticals, Inc.. Status: unknown.
02
Drugs
liposomal NDDP
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00081549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00081549.